0001193125-23-140405 Sample Contracts

AGREEMENT AND PLAN OF MERGER among: CTI BIOPHARMA CORP., a Delaware corporation; SWEDISH ORPHAN BIOVITRUM AB (PUBL), a Swedish public limited liability company; and CLEOPATRA ACQUISITION CORP., a Delaware corporation Dated as of May 10, 2023

Agreement and Plan of Merger • May 10th, 2023 • Cti Biopharma Corp • Pharmaceutical preparations • Delaware

• Contract Type
  Agreement and Plan of Merger
• Filed
  May 10th, 2023
• Company
  Cti Biopharma Corp
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

THIS AGREEMENT AND PLAN OF MERGER (“Agreement”) is made and entered into as of May 10, 2023, by and among: Swedish Orphan Biovitrum AB (publ), a Swedish public limited liability company (“Parent”); Cleopatra Acquisition Corp., a Delaware corporation and a wholly owned, indirect subsidiary of Parent (“Purchaser”); and CTI BioPharma Corp., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Exhibit A.

TENDER AND SUPPORT AGREEMENT

Tender and Support Agreement • May 10th, 2023 • Cti Biopharma Corp • Pharmaceutical preparations • Delaware

• Contract Type
  Tender and Support Agreement
• Filed
  May 10th, 2023
• Company
  Cti Biopharma Corp
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

This TENDER AND SUPPORT AGREEMENT (this “Agreement”) is made and entered into as of May 10, 2023 by and among Swedish Orphan Biovitrum AB (publ), a Swedish public limited liability company (“Parent”), Cleopatra Acquisition Corp., a Delaware corporation and a wholly owned, indirect subsidiary of Parent (“Purchaser”), and each of the undersigned stockholders (the “Stockholders”) of CTI BioPharma Corp., a Delaware corporation (the “Company”).